Brief: Puma Biotechnology Q4 Adjusted EPS USD 0.31
29/02/2024 21:05
Feb 29 (Reuters) - Puma Biotechnology Q4 operating income USD 14.8 million. * Q4 net income USD 12.3 million * Q4 pretax profit USD 12.8 million * Q4 product revenue USD 53.2 million * Q4 EPS USD 0.26 * Q4 adjusted net income USD 14.8 million
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2